Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Thyrocare Technologies Limited (NSE: THYROCARE), ISIN INE594H01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
THYROCARE last traded at ₹486.35 (-1.37%), with a 52-week range of ₹342.55 to ₹662.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 51.02%, FIIs 9.37%, DIIs 25.92%, mutual funds 22.91%.
EquiSense Score (ECS): 66/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.